Explore more publications!
Investor World Review
Got News to Share?

Investor World Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Investor World Review.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on March 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges monday.com Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Mar. 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges monday.com Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Mar. 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Plug Power Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Mar. 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges Plug Power Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Concorde International Group, Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Mar. 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges Concorde International Group, Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire
MREO DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO
Mar. 22, 2026

MREO DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO

Indeterminate GlobeNewswire
Bitcoin Everlight Opens Phase 2 Presale as Shard Activations Continue Across All Three Tiers
Mar. 22, 2026

Bitcoin Everlight Opens Phase 2 Presale as Shard Activations Continue Across All Three Tiers

Indeterminate GlobeNewswire
SOMNDEEP Introduces Contactless Sleep Monitoring Solution to Address Long-Term Wearable Drop-Off
Mar. 22, 2026

SOMNDEEP Introduces Contactless Sleep Monitoring Solution to Address Long-Term Wearable Drop-Off

Indeterminate GlobeNewswire
LETWESAF Introduces Camping Radar Security Alarm System to Help Campers Detect Threats Earlier During Spring Travel Season
Mar. 22, 2026

LETWESAF Introduces Camping Radar Security Alarm System to Help Campers Detect Threats Earlier During Spring Travel Season

Indeterminate GlobeNewswire
REVIVE Makes Landmark French Debut at VAPEXPO Paris 2026 with Four Exclusive Product Lines
Mar. 22, 2026

REVIVE Makes Landmark French Debut at VAPEXPO Paris 2026 with Four Exclusive Product Lines

Indeterminate GlobeNewswire
KWEICHOW MOUTAI Holds 2026 International Distributor Conference
Mar. 22, 2026

KWEICHOW MOUTAI Holds 2026 International Distributor Conference

Indeterminate GlobeNewswire
Crypto News: Pepeto Goes Viral While XRP Price Prediction Might Reach $10 Soon
Mar. 22, 2026

Crypto News: Pepeto Goes Viral While XRP Price Prediction Might Reach $10 Soon

Indeterminate GlobeNewswire
Crypto News: Pepeto Eliminates Ethereum Fees While XRP Price Prediction Targets $8 and Whale Wallets Are Moving
Mar. 22, 2026

Crypto News: Pepeto Eliminates Ethereum Fees While XRP Price Prediction Targets $8 and Whale Wallets Are Moving

Indeterminate GlobeNewswire
ThinkCareBelieve: Week 61 of the Trump 2.0 Administration
Mar. 22, 2026

ThinkCareBelieve: Week 61 of the Trump 2.0 Administration

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions